On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.

FDA approves Impavido to treat leishmaniasis

FDA allows marketing of first device to prevent migraine headaches

Study: CDC says improved antibiotic prescribing would reduce resistance

Benefits of exercise training in heart failure

Protocol reduces complications for complex spinal surgery

Study: U.S. women don’t know most stroke warning signs

FTC supports APRN practice in new report

Study: Gestational diabetes may increase risk for atherosclerosis later in midlife

Study: Positive self-esteem protects older adults from health problems

Call for abstracts for home care conference

Study: Fatigue common in CHD

Sustaining a shared governance organization

How Magnet® designation affects nurse retention: An evidence-based research project

Making the case for Magnet® designation to the C-suite

A new patient-acuity tool promotes equitable nurse-patient assignments

What we can learn about scheduling from the airline and package-delivery industries

One-on-one meetings: The stitch in time that saves nine

Nutrition for night-shift nurses

Living a healthy lifestyle

Improve your career with the Plan-Do-Study-Act cycle

On the CUSP: How to implement a comprehensive unit-based safety program

A roll-up-your-sleeves kind of hope

Can teach-back reduce hospital readmissions?

Touch and go for a patient with a pneumothorax

Issues up close

Health, safety, & wellness

Leadership insights

From your ANA President

Ten tips to help you reboot your nursing career

MARS®: The new frontier in treating acute liver failure

A powerful question: “Have you ever served in the military?”

6 surprising best resuscitation practices

FDA approves Omontys for anemia in dialysis patients

Study: Psychological adverse effects of antidepressants

Study: Use of antibiotics to prevent complications from respiratory infections in children isn’t supported

FDA approves Imbruvica to treat chronic lymphocytic leukemia